Rchr
J-GLOBAL ID：200901035283924315
Update date: Dec. 18, 2024
Horiguchi Yutaka
ホリグチ ユタカ | Horiguchi Yutaka
Affiliation and department：
Research field (1)：
Urology
Research keywords (2)：
泌尿器腫瘍
, Urologic Oncology
Research theme for competitive and other funds (6)：
MISC (4)：
-
Y Horiguchi, Nukaya, I, K Okazawa, Kawashima, I, J Fikes, A Sette, M Tachibana, K Takesako, M Murai. Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes. CLINICAL CANCER RESEARCH. 2002. 8. 12. 3885-3892
-
NISHIYAMA T. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with HLA-A24-Specific MAGE-3 peptide. Clinical Cancer Research. 2001. 7. 1. 23-31
-
WA Larchian, Y Horiguchi, SK Nair, WR Fair, WDW Heston, E Gilboa. Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: A liposome-mediated gene therapy treatment for bladder cancer. CLINICAL CANCER RESEARCH. 2000. 6. 7. 2913-2920
-
Y Horiguchi, WA Larchian, R Kaplinsky, WR Fair, WDW Heston. Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model. GENE THERAPY. 2000. 7. 10. 844-851
Works (6)：
-
前立腺癌におけるNF-KBを標的としたアポトーシスの誘導
2000 - 2001
-
Induction of Apoptosis in Prostate cancer by targeting NF-KB
2000 - 2001
-
前立腺癌標的遺伝子治療
1999 - 2001
-
膀胱癌に対する膀胱内免疫遺伝子治療
1999 - 2001
-
Targeting Gene Therapy for Prostate Cancer
1999 - 2001
ｍore...
Education (2)：
- - 1989 Keio University School of Medicine Depertment of Medicine
- - 1989 Keio University Faculty of Medicine
Professional career (2)：
- PhD (Keio University)
- MD (Keio University)
Work history (6)：
- 1998 - 1999 クリーブランド・クリニック・ファウンデーション 研究員
- 1998 - 1999 The Cleveland Cinic Foundation, Research
- 1996 - 1998 メモリアル・スローン-ケタリング・キャンサー・センター 研究員
- 1996 - 1998 Memorial Sloan-Kettering Cancer Center,
- Fellow
- Research Fellow
Show all
Association Membership(s) (2)：
アメリカ泌尿器科学会(American Urological Association)
, 日本泌尿器科学会
